Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol vs Formoterol in COPD
NCT01377428Phase 4Withdrawn
- Sponsor
- Novartis
- Start
- Sep 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of indacaterol in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Planned start Sep 2011; status: withdrawn.
02
Drugs
indacaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01377428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01377428.